Eribulin effective in metastatic breast cancer, researchers find

While not superior to capecitabine, eribulin is an active and well-tolerated therapy in women with metastatic breast cancer (MBC) receiving this therapy as a first, second, or third line chemotherapy regimen, researchers say. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *